US7582299B2
(en)
|
2001-04-26 |
2009-09-01 |
Biogen Idec Ma Inc. |
Cripto-specific antibodies
|
GEP20074091B
(en)
|
2001-04-26 |
2007-04-25 |
Biogen Idec Inc |
Cripto blocking antibodies and uses thereof
|
DE60239881D1
(de)
*
|
2001-09-05 |
2011-06-09 |
Genentech Inc |
Verfahren zur identifikation von polypeptid-antigenen im zusammenhang mit störungen durch aberrante zellproliferation
|
AU2003210802B2
(en)
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
HUE025101T2
(en)
|
2002-04-26 |
2016-02-29 |
Genentech Inc |
Purification of proteins other than affinity purification
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
BRPI0410842B8
(pt)
*
|
2003-05-30 |
2021-05-25 |
Agensys Inc |
método in vitro para detecção da presença de um polinucleotídeo de psca em uma amostra teste derivada de um indivíduo como um indicador da presença de câncer
|
US7595379B2
(en)
|
2003-05-30 |
2009-09-29 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
US7541442B2
(en)
|
2003-05-30 |
2009-06-02 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
AU2004252170B2
(en)
|
2003-06-27 |
2011-01-27 |
Biogen Ma Inc. |
Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
|
HUE050171T2
(hu)
|
2003-07-28 |
2020-11-30 |
Genentech Inc |
Protein-A kioldódásának csökkentése protein-A affinitáskromatográfia során
|
EP3120861B1
(en)
|
2003-11-06 |
2018-08-15 |
Seattle Genetics, Inc. |
Intermediate for conjugate preparation comprising auristatin derivatives and a linker
|
KR100747412B1
(ko)
*
|
2003-11-13 |
2007-08-07 |
주식회사유한양행 |
면역크로마토그래피법을 이용한 전립선암 및 전립선비대증 진단용 키트
|
US7767792B2
(en)
*
|
2004-02-20 |
2010-08-03 |
Ludwig Institute For Cancer Research Ltd. |
Antibodies to EGF receptor epitope peptides
|
GB0406215D0
(en)
|
2004-03-19 |
2004-04-21 |
Procure Therapeutics Ltd |
Prostate stem cell
|
AU2005250370B2
(en)
*
|
2004-05-28 |
2010-04-01 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
SI1753871T1
(sl)
*
|
2004-05-28 |
2016-01-29 |
Agensys, Inc. |
Protitelesa in sorodne molekule, ki se vežejo na psca proteine
|
CN102973947A
(zh)
|
2004-06-01 |
2013-03-20 |
健泰科生物技术公司 |
抗体-药物偶联物和方法
|
US7662926B2
(en)
|
2004-09-02 |
2010-02-16 |
Genentech, Inc. |
Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
|
US7655229B2
(en)
|
2004-09-02 |
2010-02-02 |
Chan Andrew C |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
CA2580141C
(en)
|
2004-09-23 |
2013-12-10 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
JP4993645B2
(ja)
|
2004-12-01 |
2012-08-08 |
ジェネンテック, インコーポレイテッド |
抗体薬剤結合体および方法
|
SG173313A1
(en)
|
2005-01-05 |
2011-08-29 |
Biogen Idec Inc |
Cripto binding molecules
|
EP1871882A1
(en)
*
|
2005-03-25 |
2008-01-02 |
GlycArt Biotechnology AG |
Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function
|
WO2006112933A1
(en)
*
|
2005-04-14 |
2006-10-26 |
Agensys, Inc. |
Antibodies and related molecules that bind to psca proteins
|
CN101223191B
(zh)
*
|
2005-04-14 |
2012-09-05 |
阿根西斯公司 |
与psca蛋白结合的抗体和相关分子
|
US7456259B2
(en)
*
|
2005-08-02 |
2008-11-25 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
US7456258B2
(en)
*
|
2005-08-02 |
2008-11-25 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
US7452978B2
(en)
*
|
2005-08-02 |
2008-11-18 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
CA2615122A1
(en)
|
2005-08-03 |
2007-02-15 |
Immunogen, Inc. |
Immunoconjugate formulations
|
WO2007086932A2
(en)
*
|
2006-01-13 |
2007-08-02 |
The Johns Hopkins University |
Prostate stem cell antigen vaccines and uses thereof
|
CA2646329C
(en)
*
|
2006-03-20 |
2018-07-03 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
US8163886B2
(en)
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
JP5361738B2
(ja)
|
2007-01-22 |
2013-12-04 |
ジェネンテック, インコーポレイテッド |
多価電解質沈殿物及びタンパク質の精製
|
KR101643514B1
(ko)
|
2007-07-09 |
2016-07-27 |
제넨테크, 인크. |
폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
|
CA2698343C
(en)
*
|
2007-09-04 |
2018-06-12 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
|
KR101241486B1
(ko)
|
2007-10-30 |
2013-03-15 |
제넨테크, 인크. |
양이온 교환 크로마토그래피에 의한 항체 정제
|
WO2009151514A1
(en)
|
2008-06-11 |
2009-12-17 |
Millipore Corporation |
Stirred tank bioreactor
|
WO2010019148A1
(en)
|
2008-08-14 |
2010-02-18 |
Genentech, Inc. |
Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
|
JP5705115B2
(ja)
|
2008-09-10 |
2015-04-22 |
ジェネンテック, インコーポレイテッド |
蛋白質の酸化的分解の予防のための組成物および方法
|
US20100190963A1
(en)
|
2008-12-16 |
2010-07-29 |
Millipore Corporation |
Stirred Tank Reactor And Method
|
CA2752884A1
(en)
|
2009-02-27 |
2010-09-02 |
Genentech, Inc. |
Methods and compositions for protein labelling
|
DK2464725T3
(da)
|
2009-08-11 |
2020-06-02 |
Hoffmann La Roche |
Fremstilling af proteiner i glutaminfrie celledyrkningsmedier
|
WO2011028753A1
(en)
|
2009-09-01 |
2011-03-10 |
Genentech, Inc. |
Enhanced protein purification through a modified protein a elution
|
CA2809819A1
(en)
|
2009-09-09 |
2011-03-17 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
US20120309056A1
(en)
|
2010-02-04 |
2012-12-06 |
Leon Arnaud |
Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
|
TR201905081T4
(tr)
|
2010-03-22 |
2019-05-21 |
Hoffmann La Roche |
Protein içeren formülasyonların stabilizasyonu için yararlı bileşimler ve yöntemler.
|
BR112012026213B1
(pt)
|
2010-04-15 |
2021-12-28 |
Medimmune Limited |
Compostos de pirrolobenzodiazepinas, conjugado das mesmas, composição farmacêutica compreendendo o conjugado e uso do mesmo para o tratamento de uma doença proliferativa
|
BR112012027828A2
(pt)
|
2010-05-03 |
2016-08-09 |
Genentech Inc |
composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína
|
WO2011146394A1
(en)
|
2010-05-17 |
2011-11-24 |
Millipore Corporation |
Stimulus responsive polymers for the purification of biomolecules
|
HUE030820T2
(en)
|
2010-05-28 |
2017-06-28 |
Hoffmann La Roche |
Decreasing Lactate Levels and Enhancing Polypeptide Production by Control of Lactate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression
|
AU2011265054B2
(en)
|
2010-06-08 |
2016-09-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
WO2011163458A2
(en)
|
2010-06-24 |
2011-12-29 |
Genentech, Inc. |
Compositions and methods for stabilizing protein-containing formulations
|
WO2012021773A1
(en)
|
2010-08-13 |
2012-02-16 |
Genentech, Inc. |
Antibodies to il-1beta and il-18, for treatment of disease
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
EP2640727B1
(en)
|
2010-11-17 |
2015-05-13 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
WO2012095514A1
(en)
|
2011-01-14 |
2012-07-19 |
Vivalis |
Recombinant protein production system
|
MX2013013054A
(es)
|
2011-05-12 |
2014-02-20 |
Genentech Inc |
Metodo de monitoreo de lc-ms/ms de reaccion multiple para detectar anticuerpos terapeuticos en muestras de animales utilizando peptidos de firma de estructura.
|
DE102011118022B4
(de)
*
|
2011-06-30 |
2018-01-18 |
Gemoab Monoclonals Gmbh |
Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung
|
CN103987407B
(zh)
|
2011-10-14 |
2016-08-24 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓及其偶联物
|
MY172426A
(en)
|
2011-12-22 |
2019-11-25 |
Genentech Inc |
Ion exchange membrane chromatography
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
BR112014023176B1
(pt)
|
2012-03-27 |
2021-09-28 |
Genentech, Inc. |
Métodos de produção de uma proteína recombinante
|
NZ737862A
(en)
|
2012-05-18 |
2020-01-31 |
Genentech Inc |
High-concentration monoclonal antibody formulations
|
HUE056217T2
(hu)
|
2012-07-13 |
2022-02-28 |
Roche Glycart Ag |
Bispecifikus anti-VEGF/anti-ANG-2 antitestek és ezek alkalmazása szemészeti érbetegségek kezelésében
|
CA2887894C
(en)
|
2012-10-12 |
2019-10-29 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine - anti-psma antibody conjugates
|
AU2013328580B2
(en)
|
2012-10-12 |
2016-01-21 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
PL2906298T3
(pl)
|
2012-10-12 |
2019-04-30 |
Adc Therapeutics Sa |
Koniugaty pirolobenzodiazepina - przeciwciało
|
ES2660029T3
(es)
|
2012-10-12 |
2018-03-20 |
Medimmune Limited |
Conjugados de anticuerpo-pirrolobenzodiazepinas
|
WO2014057114A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
NZ707490A
(en)
|
2012-10-12 |
2018-09-28 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
PT2906296T
(pt)
|
2012-10-12 |
2018-06-01 |
Medimmune Ltd |
Conjugados de pirrolobenzodiazepina-anticorpo
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
WO2014100095A1
(en)
|
2012-12-19 |
2014-06-26 |
Genentech, Inc. |
Methods and compositions for radiohalogen protein labeling
|
AU2013366490B9
(en)
|
2012-12-21 |
2018-02-01 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
ES2658888T5
(es)
|
2012-12-21 |
2021-10-19 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
MX364330B
(es)
|
2013-03-13 |
2019-04-23 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas.
|
TWI680766B
(zh)
|
2013-03-13 |
2020-01-01 |
英商梅迪繆思有限公司 |
吡咯并苯并二氮呯及其共軛物
|
WO2014140174A1
(en)
|
2013-03-13 |
2014-09-18 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
EP3033111B1
(en)
|
2013-08-12 |
2019-03-13 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
EP3054985B1
(en)
|
2013-10-11 |
2018-12-26 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
EP3054986B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
EP3054983B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
BR112016013258A2
(pt)
|
2013-12-16 |
2018-01-16 |
Genentech Inc |
composto conjugado anticorpo-droga, composição farmacêutica, método para tratar câncer e kit
|
WO2015095223A2
(en)
|
2013-12-16 |
2015-06-25 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
PE20161394A1
(es)
|
2013-12-16 |
2017-01-06 |
Genentech Inc |
Compuestos peptidomimeticos y sus conjugados de anticuerpo-farmaco
|
MX2017000231A
(es)
|
2014-07-09 |
2017-06-27 |
Genentech Inc |
Ajuste del ph para mejorar la recuperacion por descongelamiento de bancos de celulas.
|
JP6531166B2
(ja)
|
2014-09-10 |
2019-06-12 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
WO2016040825A1
(en)
|
2014-09-12 |
2016-03-17 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
SG11201701128YA
(en)
|
2014-09-12 |
2017-03-30 |
Genentech Inc |
Cysteine engineered antibodies and conjugates
|
SG11201702079UA
(en)
|
2014-09-17 |
2017-04-27 |
Genentech Inc |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
MX2017006770A
(es)
|
2014-11-25 |
2018-02-09 |
Adc Therapeutics Sa |
Conjugados de pirrolobenzodiazepina y anticuerpo.
|
JP6752204B2
(ja)
|
2014-12-03 |
2020-09-09 |
ジェネンテック, インコーポレイテッド |
四級アミン化合物及びその抗体−薬物コンジュゲート
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
US20170315132A1
(en)
|
2016-03-25 |
2017-11-02 |
Genentech, Inc. |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
CN109312299A
(zh)
|
2016-03-29 |
2019-02-05 |
格尔托公司 |
蛋白质在具有0.5:1至10:1的周质体积与细胞质体积比的革兰氏阴性菌中的表达
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
WO2017197045A1
(en)
|
2016-05-11 |
2017-11-16 |
Movassaghi Mohammad |
Convergent and enantioselective total synthesis of communesin analogs
|
EP3458101B1
(en)
|
2016-05-20 |
2020-12-30 |
H. Hoffnabb-La Roche Ag |
Protac antibody conjugates and methods of use
|
WO2017205741A1
(en)
|
2016-05-27 |
2017-11-30 |
Genentech, Inc. |
Bioanalytical method for the characterization of site-specific antibody-drug conjugates
|
EP3464280B1
(en)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol antibody-drug conjugates and methods of use
|
JP7093767B2
(ja)
|
2016-08-11 |
2022-06-30 |
ジェネンテック, インコーポレイテッド |
ピロロベンゾジアゼピンプロドラッグ及びその抗体コンジュゲート
|
EP3522933B1
(en)
|
2016-10-05 |
2021-12-15 |
F. Hoffmann-La Roche AG |
Methods for preparing antibody drug conjugates
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
EP3558366A1
(en)
|
2016-12-22 |
2019-10-30 |
H. Hoffnabb-La Roche Ag |
Methods and formulations for reducing reconstitution time of lyophilized polypeptides
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
DK3544636T3
(da)
|
2017-02-08 |
2021-05-10 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepin-antistof-konjugater
|
CN110582505B
(zh)
|
2017-04-18 |
2021-04-02 |
免疫医疗有限公司 |
吡咯并苯并二氮杂*缀合物
|
CA3057748A1
(en)
|
2017-04-20 |
2018-10-25 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
WO2018209239A1
(en)
|
2017-05-11 |
2018-11-15 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
AU2018285562B2
(en)
|
2017-06-14 |
2024-01-18 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-CD19 ADC
|
RS62928B1
(sr)
|
2017-08-18 |
2022-03-31 |
Medimmune Ltd |
Konjugati pirolobenzodiazepina
|
IL273387B2
(en)
|
2017-09-20 |
2023-10-01 |
Ph Pharma Co Ltd |
Thylanstatin analogs
|
US11180541B2
(en)
|
2017-09-28 |
2021-11-23 |
Geltor, Inc. |
Recombinant collagen and elastin molecules and uses thereof
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
JP7419273B2
(ja)
|
2018-07-03 |
2024-01-22 |
ブリストル-マイヤーズ スクイブ カンパニー |
組換えタンパク質を製造する方法
|
WO2020009165A1
(ja)
*
|
2018-07-03 |
2020-01-09 |
味の素株式会社 |
修飾抗体およびその製造方法
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
KR20210074341A
(ko)
|
2018-10-10 |
2021-06-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
고밀도 생물 반응기 배양에서 막 기체 전달을 위한 방법
|
EP3870235A1
(en)
|
2018-10-24 |
2021-09-01 |
F. Hoffmann-La Roche AG |
Conjugated chemical inducers of degradation and methods of use
|
JP2022513198A
(ja)
|
2018-12-10 |
2022-02-07 |
ジェネンテック, インコーポレイテッド |
Fc含有タンパク質への部位特異的コンジュゲーションのための光架橋性ペプチド
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
WO2020205716A1
(en)
|
2019-04-01 |
2020-10-08 |
Genentech, Inc. |
Compositions and methods for stabilizing protein-containing formulations
|
KR20210151930A
(ko)
|
2019-04-12 |
2021-12-14 |
젤터, 인코포레이티드 |
재조합 엘라스틴 및 이의 제조
|
CN114514311A
(zh)
|
2019-08-01 |
2022-05-17 |
百时美施贵宝公司 |
改进补料分批细胞培养物中蛋白质产量的方法
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
JP2023542924A
(ja)
|
2020-09-22 |
2023-10-12 |
ブリストル-マイヤーズ スクイブ カンパニー |
治療タンパク質を生産するための方法
|
WO2023015234A1
(en)
|
2021-08-05 |
2023-02-09 |
Bristol-Myers Squibb Company |
Cell culture methods for producing therapeutic proteins
|
WO2023049687A1
(en)
|
2021-09-21 |
2023-03-30 |
Bristol-Myers Squibb Company |
Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container
|